Empowering Research with Organ-on-Chip Technologies

Abstract

Organ-on-chip technologies are transforming in vitro modeling by providing physiologically relevant platforms that better recapitulate human tissue function. These microfluidic devices enable the development of advanced models that mimic key aspects of human physiology, including cellular interactions, barrier functions, and dynamic microenvironments.
This talk will highlight how organ-on-chip systems can support researchers in improving the predictive power of preclinical studies, accelerating drug discovery, and enabling more reliable disease modeling. By bridging the gap between traditional cell culture and in vivo studies, these platforms offer a powerful tool to enhance translational research while reducing reliance on animal models.

Bio

Dr. Rosa Monge is CEO and co-founder of BEONCHIP S.L., a leading company in organ-on-chip technology, founded in 2016 to bring cutting-edge microfluidic innovations to the biomedical field. With a PhD in Mechanical Engineering from the University of Zaragoza, she has been at the forefront of developing advanced in vitro systems that improve the predictive power of preclinical research.
She has authored multiple scientific publications and holds six patents in microfluidic device design. Recognized with more than 15 awards in innovation, research, and entrepreneurship, Dr. Monge combines scientific expertise with strong leadership to drive the adoption of next-generation in vitro models.

Host PI: Mabel Loza, Pharmacology Applied to Drug Discovery group, CiMUS.

Certificates of attendance will be issued after the conference upon request by emailing cimus.xestion [at] usc.es (cimus[dot]xestion[at]usc[dot]es). Please remember to provide your full name and surname when attending the conference.